General Ophthalmology - Eye Health Academy

17-32 of 55

The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Eye on Ocular Health
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
- Lisa Schocket, MD
Strategies for Addressing Complications in Retinal Vein Occlusion
Strategies for Addressing Complications in Retinal Vein Occlusion
Eye on Ocular Health
Strategies for Addressing Complications in Retinal Vein Occlusion
- Lisa Schocket, MD
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Eye on Ocular Health
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
- Houman Hemmati, MD, PhD
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Eye on Ocular Health
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
- Houman Hemmati, MD, PhD
Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
AAO Action Center
Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
AAO Action Center
Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
- Anat Galor, MD, MSPH
Personalizing Treatment for Chronic Ocular Surface Pain
Personalizing Treatment for Chronic Ocular Surface Pain
AAO Action Center
Personalizing Treatment for Chronic Ocular Surface Pain
- Anat Galor, MD, MSPH
Targeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
Targeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
AAO Action Center
Targeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
Comparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
Comparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
Eye on Ocular Health
Comparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
- Charles Turck, PharmD, BCPS, BCCCP
- Michael Javaheri, MD, MSc, FASRS
Optimizing Anti-VEGF Sequencing: Strategies to Reduce Burden and Personalize Care
Optimizing Anti-VEGF Sequencing: Strategies to Reduce Burden and Personalize Care
Eye on Ocular Health
Optimizing Anti-VEGF Sequencing: Strategies to Reduce Burden and Personalize Care
- Brian P. McDonough, MD, FAAFP
- Mitchell J. Goff, MD, FASRS
Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
Eye on Ocular Health
Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
- Charles Turck, PharmD, BCPS, BCCCP
- Joseph M. Coney, MD
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Eye on Ocular Health
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
- Marlene Mimi Maeusli, PhD.
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Eye on Ocular Health
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
- Marlene Mimi Maeusli, PhD.
Myopia Control in Europe: The Case for Upfront Investment in Childhood
Myopia Control in Europe: The Case for Upfront Investment in Childhood
Eye on Ocular Health
Myopia Control in Europe: The Case for Upfront Investment in Childhood
Combination Therapy Slows Myopia Progression in Children with Premyopia
Combination Therapy Slows Myopia Progression in Children with Premyopia
Eye on Ocular Health
Combination Therapy Slows Myopia Progression in Children with Premyopia
Tackling the Myopia Epidemic: Causes, Consequences, and Opportunities for Prevention
Tackling the Myopia Epidemic: Causes, Consequences, and Opportunities for Prevention
Eye on Ocular Health
Tackling the Myopia Epidemic: Causes, Consequences, and Opportunities for Prevention
- Ryan Quigley
- Michael D. Twa, OD, PhD, FAAO
- David A. Berntsen, OD, PhD, FAAO

2/4